Chi Michael

Chief Operating Officer Chi Michael sells 97,289 shares of HIMS at $24.69; stock now down 65.0% from 52-week high.

Chi Michael, Chief Operating Officer of Hims & Hers Health, Inc., executed a significant sale of 97,289 shares at $24.69 on 2026-03-17, reducing his holdings by 19.3%. The transaction is notable within the context of recent price action: the stock has declined from a 52-week high of $66.18 to a current price of $23.15 (-65.0%), yet has recovered 42.0% over the past 30 days. Michael's prior four sales at HIMS have been well-timed at the 90-day horizon, demonstrating a consistent pattern of selling ahead of declines. However, the current sale occurs after substantial recovery momentum (+42.0% in 30 days), which differs tactically from the typical pattern of his prior trades executed when the stock faced deteriorating conditions. The company's fundamentals remain solid—annual revenue growth of 59.0% and net income of $15,774,000.00—suggesting this transaction may reflect portfolio management rather than a signal of deteriorating business prospects.

COO Chi Michael sold 13,750 HIMS shares at $36.71; stock now $34.77, -49.4% from 52-week high. Track record shows 84.62% well-timed sells.

Chi Michael, Chief Operating Officer, sold 13,750 shares of Hims & Hers at $36.71 on 2025-12-17, reducing holdings by 4.3% to 305,161 shares. The sale occurred when the stock was trading near the high end of its 52-week range ($24.18–$68.74); since the transaction, HIMS has fallen to $34.77, or -49.4% from its 52-week high and now trading 5.3% below Michael's sale price. His cross-ticker track record demonstrates a 84.62% well-timed sell rate across 13 prior open-market sales, with an average 90-day return of -19.0%, and at HIMS specifically, four of his five prior sells were well-timed at the 90-day mark. This consistent pattern of selling ahead of subsequent declines, combined with the magnitude of the current drawdown since his sale, suggests the transaction aligns with his demonstrated ability to exit positions before material price weakness. The context includes strong fundamentals (annual revenue growth +69.3%, $599.0M latest quarter revenue), but the sharp 90-day decline of -39.9% and P/E of 59.95 indicate valuation compression that may have motivated the exit.

CCO Michael Chi sells 26,600 HIMS shares for $1,781,560.00; post-transaction holdings 278.7K shares; stock near 52-week high

Chi Michael, Chief Commercial Officer, executed 2 separate sales totaling 26,600 shares for $1,781,560.00 at a blended average price of $66.98 on July 31–August 1, 2025. This represents an 8.7% reduction in his holdings (from 305.3K to 278.7K shares), occurring as the stock trades near its 52-week high of $68.74 and has appreciated +32.0% over the prior 30 days and +28.1% over 90 days. His cross-ticker track record shows a 90-day well-timed rate of 80.00%, but his same-ticker history at HIMS is mixed: 3 of 4 prior measurable 90-day outcomes were negative (well-timed), though one October 2024 sale was followed by a +17.7% 90-day gain. Fundamental context shows HIMS reporting $544.8M quarterly revenue with strong +69.3% annual growth and $42.5M net income, though the elevated P/E of 109.22 suggests significant valuation premium relative to near-term earnings.

CCO Chi Michael sells 17,102 HIMS shares at $59.75; stock down 8.4% in 30d, down 13.8% from 52w high.

Chi Michael, Chief Commercial Officer, sold 17,102 shares at $59.75 on 2025-06-17, reducing holdings by 5.8% to 278,654 shares and raising $1,021,844.50. The transaction occurs amid recent weakness: HIMS is down 8.4% over the past 30 days and down 13.8% from its 52-week high of $68.74, though the stock has surged 74.8% over 90 days. At Michael's same-ticker history at HIMS, 4 of 5 prior sells showed negative 90-day returns (well-timed pattern), suggesting he has historically exited before declines. His cross-ticker track record shows an 80.00% well-timed sell rate and a -17.5% average 90-day return after sales, indicating his prior open-market dispositions have often preceded market weakness. Fundamentally, HIMS remains on a growth trajectory with FY revenue growth of +69.3% and a latest quarterly revenue of $586.0M with $49.5M net income, though the stock trades at a P/E of 102.14. The timing and magnitude of this sale, combined with his demonstrated pattern of selling ahead of declines, warrants investor attention.

CCO Chi Michael sells 75,493 HIMS shares (-28.0% of holdings) at $22.00; all 5 prior HIMS sales were well-timed 90d declines

Chi Michael, Chief Commercial Officer, sold 75,493 shares at $22.00 on 2024-10-15, reducing his holdings by 28.0% from 269,473 to 193,980 shares. His prior HIMS transaction history shows 5 of 5 prior sells were well-timed at the 90-day mark, with 90-day returns of -4.6%, -8.2%, -29.9%, -27.6%, and -27.6% respectively. His cross-ticker track record demonstrates a 90-day well-timed rate of 88.89%, indicating a consistent pattern of selling before downturns. The current stock price of $22.36 is -9.8% from the 52-week high of $24.79, and while the stock has rallied +37.4% in the past 30 days, the insider's transaction history suggests caution about recent momentum. HIMS remains unprofitable on a full-year basis despite strong 65.5% annual revenue growth, presenting a valuation tension between growth and profitability metrics.